Fritextsökning
Innehållstyper
-
New CEO to Promedvi
Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.
-
Dupont gets new business manager
The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
DKK 1,3 billion for grand research
Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.
-
Eli Lilly writes biotech fine history
The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.
-
View pathology images in your iPhone
The Institute for Medical Informatics in Oslo announces a brand new iPhone application for virtual microscopy.
-
Alligator kliver ut på börsen
Noteras på börslistan Nasdaq Stockholm.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Biovitrum sells UK part
Biovitrum will soon spin-out a British subsidary
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Control of blood vessels can treat obesity
Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet.
-
Varnar för Astra-preparat
FDA går ut med ännu en varning för läkemedelsklassen SGLT2-hämmare.
-
Clinical trials in large scale to Stockholm
Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Test if you carry the fat virus
In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.
-
Fusion between pharma giants?
It is rumoured that a fusion between Pfizer and Wyeth is in the process of happening.
-
XNK Therapeutics värvar vetenskapliga rådgivare
Det svenska immunterapiföretaget XNK Therapeutics tar in extra expertis i företaget för att stärka sin plattformsteknologi.
-
Läkemedelsverket om nya regelverket: Stora utmaningar att hinna med
Det är bråda tider på Läkemedelsverket inför införandet av det nya regelverket IVDR den 26 maj. "Övergångstiderna som finns har gett oss mer tid, men vi ser änd...
-
Mathematician new dean at DTU
On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.
-
Bico gör miljardförvärv i USA
Biokonvergensbolaget Bico Group har ingått avtal om att förvärva amerikanska Biosero för närmare 1,5 miljarder kronor. Enligt Bico ger affären möjlighet till st...
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Blixtsnabb utveckling inom blodanalys – "Det är Sverige som leder racet"
Tusentals analytiska tester – med hjälp av en enda droppe blod. Det som avslöjades som en bluff för bara några år sedan är nu verklighet, enligt KTH-professorn ...
BREAKING